|
1
|
Kallioniemi A, Kallioniemi OP, Sudar D, et
al: Comparative genomic hybridization for molecular cytogenetic
analysis of solid tumors. Science. 258:818–821. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weiss MM, Hermsen MA, Meijer GA, et al:
Comparative genomic hybridisation. Mol Pathol. 52:243–251. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pinkel D and Albertson DG: Array
comparative genomic hybridization and its applications in cancer.
Nat Genet. 37 Suppl:S11–S17. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Forozan F, Karhu R, Kononen J, Kallioniemi
A and Kallioniemi OP: Genome screening by comparative genomic
hybridization. Trends Genet. 13:405–409. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oostlander AE, Meijer GA and Ylstra B:
Microarray-based comparative genomic hybridization and its
applications in human genetics. Clin Genet. 66:488–495. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang L, Parkin DM, Ferlay J, Li L and Chen
Y: Estimates of cancer incidence in China for 2000 and projections
for 2005. Cancer Epidemiol Biomarkers Prev. 14:243–250.
2005.PubMed/NCBI
|
|
7
|
Stratton MR and Rahman N: The emerging
landscape of breast cancer susceptibility. Nat Genet. 40:17–22.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kallioniemi A, Kallioniemi OP, Piper J,
Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW and Waldman
FM: Detection and mapping of amplified DNA sequences in breast
cancer by comparative genomic hybridization. Proc Natl Acad Sci
USA. 91:2156–2160. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abulhasan SJ, Tayel SM and Al-Awadi SA:
Mosaic Turner syndrome: cytogenetics versus FISH. Ann Hum Genet 63
(Pt 3). 199–206. 1999. View Article : Google Scholar
|
|
10
|
Wei F, Ni J, Wu SS, Liu H, Xu X, Han YL,
Cai Y, Zhang JW, Chen XJ, Pang H, et al: Cytogenetic studies of
esophageal squamous cell carcinomas in the northern Chinese
population by comparative genomic hybridization. Cancer Genet
Cytogenet. 138:38–43. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
du Manoir S, Schröck E, Bentz M, Speicher
MR, Joos S, Ried T, Lichter P and Cremer T: Quantitative analysis
of comparative genomic hybridization. Cytometry. 19:27–41. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stacher E, Boldt V, Leibl S, Halbwedl I,
Popper HH, Ullmann R, Tavassoli FA and Moinfar F: Chromosomal
aberrations as detected by array comparative genomic hybridization
in early low-grade intraepithelial neoplasias of the breast.
Histopathology. 59:549–555. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang XR, Killian JK, Hammond S, et al:
Characterization of genomic alterations in radiation-associated
breast cancer among childhood cancer survivors, using comparative
genomic hybridization (CGH) arrays. PLoS One. 10:e01160782015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bonnet F, Guedj M, Jones N, et al: An
array CGH based genomic instability index (G2I) is predictive of
clinical outcome in breast cancer and reveals a subset of tumors
without lymph node involvement but with poor prognosis. BMC Med
Genomics. 5:542012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Arnedos M, Scott V, Job B, et al: Array
CGH and PIK3CA/AKT1 mutations to drive patients to specific
targeted agents: a clinical experience in 108 patients with
metastatic breast cancer. Eur J Cancer. 48:2293–2299. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
du Manoir S, Speicher MR, Joos S, Schröck
E, Popp S, Döhner H, Kovacs G, Robert-Nicoud M, Lichter P and
Cremer T: Detection of complete and partial chromosome gains and
losses by comparative genomic in situ hybridization. Hum Genet.
90:590–610. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim SW, Kim JW, Kim YT, Kim JH, Kim S,
Yoon BS, Nam EJ and Kim HY: Analysis of chromosomal changes in
serous ovarian carcinoma using high-resolution array comparative
genomic hybridization: Potential predictive markers of
chemoresistant disease. Genes Chromosomes Cancer. 46:1–9. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Corrêa NC, Kuasne H, Faria JA, Seixas CC,
Santos IG, Abreu FB, Nonogaki S, Rocha RM, Aparecida Borges Silva
G, Gobbi H, et al: Genomic and phenotypic profiles of two Brazilian
breast cancer cell lines derived from primary human tumors. Oncol
Rep. 29:1299–1307. 2013.PubMed/NCBI
|
|
19
|
Ross JS and Fletcher JA: The HER-2/neu
oncogene in breast cancer: Prognostic factor, predictive factor,
and target for therapy. Stem Cells. 16:413–428. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han W, Woo JH, Jeon YK, Yang SJ, Cho J, Ko
E, Kim TY, Im SA, Oh DY, Park IA, et al: 17p12 deletion in breast
cancer predicts resistance to neoadjuvant chemotherapy. Exp Ther
Med. 2:799–804. 2011.PubMed/NCBI
|
|
21
|
Al Kuraya K, Schraml P, Torhorst J, Tapia
C, Zaharieva B, Novotny H, Spichtin H, Maurer R, Mirlacher M,
Köchli O, et al: Prognostic relevance of gene amplifications and
coamplifications in breast cancer. Cancer Res. 64:8534–8540. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun Q, Yang YM, Yu SH, Zhang YX, He XG,
Sun SS, Liang XS and Pang D: Covariation of copy number located at
16q22.1: New evidence in mammary ductal carcinoma. Oncol Rep.
28:2156–2162. 2012.PubMed/NCBI
|
|
23
|
Larramendy ML, Lushnikova T, Björkqvist
AM, Wistuba II, Virmani AK, Shivapurkar N, Gazdar AF and Knuutila
S: Comparative genomic hybridization reveals complex genetic
changes in primary breast cancer tumors and their cell lines.
Cancer Genet Cytogenet. 119:132–138. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishizaki T, DeVries S, Chew K, et al:
Genetic alterations in primary breast cancers and their metastases:
Direct comparison using modified comparative genomic hybridization.
Genes Chromosomes Cancer. 19:267–272. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nishizaki T, Chew K, Chu L, Isola J,
Kallioniemi A, Weidner N and Waldman FM: Genetic alterations in
lobular breast cancer by comparative genomic hybridization. Int J
Cancer. 74:513–517. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yeatman TJ, Cantor AB, Smith TJ, et al:
Tumor biology of infiltrating lobular carcinoma. Implications for
management. Ann Surg. 222:549–561. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Richard F, PacynaGengelbach M, Schlüns K,
Fleige B, Winzer KJ, Szymas J, Dietel M, Petersen I and Schwendel
A: Patterns of chromosomal imbalances in invasive breast cancer.
Int J Cancer. 89:305–310. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
MalamouMitsi VD, Syrrou M, Georgiou I,
Pagoulatos G and Agnantis NJ: Analysis of chromosomal aberrations
in breast cancer by comparative genomic hybridization (CGH).
Correlation with histoprognostic variables and c-erbB-2
immunoexpression. J Exp Clin Cancer Res. 18:357–361.
1999.PubMed/NCBI
|
|
29
|
Fung LF, Wong N, Tang N, Lau A, Wong V,
Pang CP, Suen M, King W and Johnson PJ: Genetic imbalances in pT2
breast cancers of southern Chinese women. Cancer Genet Cytogenet.
124:56–61. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mertens F, Johansson B, Höglund M and
Mitelman F: Chromosomal imbalance maps of malignant solid tumors: A
cytogenetic survey of 3185 neoplasms. Cancer Res. 57:2765–2780.
1997.PubMed/NCBI
|
